Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Cancer Screening Programme

Dáil Éireann Debate, Wednesday - 2 November 2011

Wednesday, 2 November 2011

Ceisteanna (511, 512)

Sean Fleming

Ceist:

521 Deputy Sean Fleming asked the Minister for Health the arrangements in place in relation to a national screening for prostate cancer; and if he will make a statement on the matter. [32198/11]

Amharc ar fhreagra

Freagraí scríofa

International evidence does not support the introduction of a population based screening programme for prostate cancer at this time. The Department and the HSE are keeping emerging international evidence under review including the results of randomised trials that are currently being conducted internationally.

Rather the focus is on improving services for those with prostate cancer, and in this regard, Rapid Access Prostate Cancer Diagnostic Clinics are now operational in six of the eight designated cancer centres. Two further clinics are due to open later this year. Patients who are judged to be at higher risk of prostate cancer, based on agreed high risk criteria, are fast-tracked directly to these clinics. These patients will have access to a multi-disciplinary specialist cancer consultation regarding appropriate management. I would encourage any man who has concerns to contact his GP for advice and appropriate referral, as required.

Sean Fleming

Ceist:

522 Deputy Sean Fleming asked the Minister for Health the age group covered by the national BreastCheck campaign; the situation in relation to ladies who are over this age limit; the facility in place to allow them have a breast check carried out through the Health Service Executive; and if he will make a statement on the matter. [32200/11]

Amharc ar fhreagra

The BreastCheck Programme provides free mammograms to all women aged 50-64. The Programme for Government includes the extension of BreastCheck to women in the 65-69 age group, in keeping with EU Guidelines on effective screening for breast cancer. In addition, the extension of the BreastCheck programme has been listed as a priority in the HSE's 3 year Corporate Plan. The HSE's National Cancer Control Programme is examining how it can extend the programme to 65-69 year olds.

Women of any age who have concerns about breast cancer should seek the advice of their GP who will, if appropriate, refer them to the symptomatic breast services in one of the eight designated specialist cancer centres.

Barr
Roinn